Suppression of type II collagen-induced arthritis by ICM0301B, a new angiogenesis inhibitor
スポンサーリンク
概要
- 論文の詳細を見る
- 2013-04-25
著者
-
Masuda Tohru
Institute For Chemotherapy M. C. R. F.
-
Ikeda Daishiro
Institute of Bioorganic Chemistry
-
OHBA Shun-ichi
Institute of Microbial Chemistry, Numazu, Microbial Chemistry Research Foundation
関連論文
- Structure of Ericamycin Having a 2-Azhexaphene Ring System
- Selective Deoxygenation and O-Methylation of Benanomicin A:Synthesis of 9-Deoxy-, 9-O-Methyl- and 14-O-Methylbenanomicin A
- A Synthetic Approach to Benanomicin A 2. Synthesis of the Substituted 5,6-Dihydrobenzo[a]naphthacenequinone
- A Synthetic Approach to Benanomicin A 1. Synthesis of 5,6-Dihydrobenzo[a]naphthacenequinone
- Synthesis an Optically Active α-Tetralone : A Key Intermediate to Natural Benanomicinone
- Inhibitory Activity of Dome Formation in LLC-PK_1 Cells Is a Selective Index of Aminoglycoside Nephrotoxicity
- Tyropeptins A and B, New Proteasome Inhibitors Produced by Kitasatospora sp. MK993-dF2 : II. Structure Determination and Synthesis
- Heliquinomycin, a New Inhibitor of DNA Helicase, Produced by Streptomyces sp. MJ929-SF2 II. Structure Determination of Heliquinomycin
- Decatromicins A and B, New Antibiotics Produced by Actinomadura sp. MK73-NF4 II. Structure Determination
- Differential localization of T_h1 and T_h2 cells in autoimmune gastritis
- The Long-lasting Antiproliferative Effect of 15-Deoxyspergualin through its Spermidine Moiety
- Inhibitory Effect of Cytostatin on Spontaneous Lung Metastases of B16-BL6 Melanoma Cells
- Modulation of Macrophage Activity in Tumor Bearing Mice by Cytogenin
- Antitumor Activity of Cytogenin
- NBRI17671, a new antitumor compound, produced by Acremonium sp. CR 17671
- NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716
- Citric acid inhibits a bacterial ceramidase and alleviates atopic dermatitis in an animal model
- A synthesis of 3'-deoxybutirosin B.
- Suppression of type II collagen-induced arthritis by ICM0301B, a new angiogenesis inhibitor